Xometry, Inc. Class A Common Stock
XMTR
$98.44
-6.11%
Xometry operates an AI-enabled on-demand manufacturing marketplace, connecting buyers of custom parts (engineers, product designers) with a global network of manufacturing partners offering services like CNC machining, 3D printing, and injection molding. As a digital platform disrupting the traditional industrial manufacturing sector, Xometry differentiates itself through its proprietary AI that provides instant quoting and optimized supplier matching. The current investor narrative centers on the company's accelerating growth trajectory, driven by expanding its supplier network and international presence, while the path to profitability remains a key debate as the company balances scale with margin improvement.…
XMTR
Xometry, Inc. Class A Common Stock
$98.44
Investment Opinion: Should I buy XMTR Today?
Rating: Hold. Xometry is a high-growth industrial platform with strong momentum, but its premium valuation and lack of profitability warrant caution. The consensus analyst rating is Buy with an average target of $96.25, implying limited near-term upside from the current price of $98.54.
Supporting Evidence: The primary valuation metric, trailing PS ratio of 4.40x, is well above the industry average of 1-2x, reflecting high growth expectations. Revenue growth is robust, with estimated next-year revenue of $1.22 billion, and gross margin of 39.1% is healthy. However, the company is not yet profitable, with a negative EPS of -$0.02, though analysts project a sharp turnaround to EPS of $1.75. Free cash flow is minimal, as indicated by a PCF ratio of 496.5. The upside to the analyst high target of $126 is 27.9%, but the average target suggests the stock is fairly valued.
Risks & Conditions: The biggest risks are failure to achieve profitability, revenue deceleration, and valuation compression. This Hold rating would upgrade to Buy if the stock pulls back to the low target of $78 or if the company reports positive EPS earlier than expected. It would downgrade to Sell if revenue growth falls below 20% or if margins deteriorate. Overall, Xometry is overvalued relative to its history and peers, but the growth trajectory partially justifies the premium.
Sign up to view all
XMTR 12-Month Price Forecast
Xometry's outlook is balanced between strong growth and high valuation. The base case of continued growth with gradual margin improvement is most likely, but the stock's premium pricing leaves little room for error. The AI assessment is neutral because while the growth story is compelling, the risk of overvaluation and the lack of current profitability create uncertainty. An upgrade to bullish would require evidence of accelerating revenue growth and margin expansion, while a downgrade to bearish would follow a significant miss on earnings or guidance.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Xometry, Inc. Class A Common Stock's 12-month outlook, with a consensus price target around $96.25 and implied upside of -2.2% versus the current price.
Average Target
$96.25
0 analysts
Implied Upside
-2.2%
vs. current price
Analyst Count
—
covering this stock
Price Range
$78 - $126
Analyst target range
Xometry is covered by 8 analysts, with a consensus recommendation of 'Buy' (mean rating 1.78 on a 1-5 scale, where 1 is Strong Buy). The average price target is $96.25, implying a slight 2.3% downside from the current price of $98.54, suggesting the stock is fairly valued near-term. The distribution leans bullish, with no sell ratings indicated. The target range spans from a low of $78.00 to a high of $126.00. The high target of $126 assumes continued growth acceleration and successful margin expansion, potentially driven by international expansion and AI-driven efficiencies. The low target of $78 reflects risks such as slower growth, competitive pressure, or failure to achieve profitability. The spread between low and high ($48) is wide relative to the average target, indicating high uncertainty about the company's future performance. Recent analyst actions are not provided, but the consensus remains positive, aligning with the strong price momentum.
Bulls vs Bears: XMTR Investment Factors
Xometry presents a high-growth, high-risk investment opportunity. The bull case is anchored by exceptional revenue growth, strong price momentum, and improving margins, with analysts projecting a turnaround to profitability. However, the stock trades at a significant premium to industry peers, with negative earnings and high debt levels. The single most important tension is whether the company can achieve the projected profitability (EPS of $1.75) while sustaining its growth rate; if it does, the current valuation may be justified, but any miss could trigger a sharp re-rating. Currently, the bull case has stronger evidence given the momentum and analyst support, but the risk of overvaluation remains substantial.
Bullish
- Exceptional Revenue Growth Trajectory: Xometry's estimated revenue for the next fiscal year is $1.22 billion, implying a significant scale-up from prior periods. The forward PS ratio of 2.47x reflects market expectations of continued high growth, supported by the company's AI-enabled platform disrupting traditional manufacturing.
- Strong Price Momentum and Relative Strength: The stock has surged 179.8% over the past year, dramatically outperforming the S&P 500's 18.4% gain. The 1-year relative strength of 161.4% underscores the stock's leadership, with the current price at 96.6% of its 52-week high of $102.00, indicating strong momentum.
- Healthy Gross Margin and Improving Operating Margin: Gross margin of 39.1% is healthy for a manufacturing platform, and operating margin of -6.6% indicates improving cost efficiency as the company scales. Analysts project positive EPS of $1.75 in the coming year, suggesting a sharp turnaround to profitability.
- Strong Liquidity Position: The current ratio of 3.76 indicates strong short-term liquidity, providing a buffer against operational volatility. This financial flexibility supports the company's ability to invest in growth initiatives without immediate cash flow concerns.
Bearish
- Negative Earnings and High Valuation: Xometry is not yet profitable, with a trailing EPS of -$0.02 and net margin of -9.0%. The trailing PS ratio of 4.40x is a 120-340% premium to the industrial machinery industry average of 1-2x, making the stock expensive relative to peers.
- High Debt-to-Equity and Negative ROE: Debt-to-equity ratio of 1.27 indicates moderate leverage, while return on equity is deeply negative at -22.4%, reflecting current unprofitability relative to equity base. This financial structure increases risk if growth slows.
- Limited Downside Support from Analyst Targets: The average analyst price target of $96.25 implies a slight 2.3% downside from the current price, suggesting the stock is fairly valued near-term. The low target of $78 represents a 20.8% downside, indicating significant risk if growth disappoints.
- High Volatility and Potential Overextension: With a beta of 1.27, the stock is 27% more volatile than the market. The price is near its 52-week high, and the 1-month gain of 10.9% and 3-month gain of 99.5% suggest potential overextension, increasing the risk of a pullback.
XMTR Technical Analysis
Xometry is in a powerful sustained uptrend, with the stock surging 179.8% over the past year, dramatically outperforming the S&P 500's 18.4% gain. The current price of $98.54 sits at 96.6% of its 52-week range ($30.63 to $102.00), indicating the stock is near its highs and reflecting strong momentum, though it also suggests the potential for overextension. The 52-week low of $30.63 provides a clear historical support level, while the high of $102.00 is a key resistance. Short-term momentum is accelerating, with a 1-month gain of 10.9% and a 3-month gain of 99.5%, far outpacing the S&P 500's 0.3% and 4.7% returns, respectively. This divergence from the broader market highlights strong stock-specific catalysts, likely tied to recent earnings or growth announcements. The 1-month trend aligns with the 1-year trend, confirming the uptrend's strength. The stock's beta of 1.27 indicates it is 27% more volatile than the market, meaning it amplifies market moves. The 52-week high of $102.00 serves as immediate resistance; a breakout above this level could signal further upside toward analyst high targets. Conversely, a pullback could find support near the $90 area, with the 52-week low of $30.63 as a distant floor. The relative strength versus the S&P 500 is exceptional, with a 1-year relative strength of 161.4%, underscoring the stock's leadership.
Beta
1.27
1.27x market volatility
Max Drawdown
-49.9%
Largest decline past year
52-Week Range
$31-$106
Price range past year
Annual Return
+209.6%
Cumulative gain past year
| Period | XMTR Return | S&P 500 |
|---|---|---|
| 1m | +7.5% | +0.4% |
| 3m | +110.0% | +5.5% |
| 6m | +59.9% | +8.4% |
| 1y | +209.6% | +18.9% |
| ytd | +56.9% | +9.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
XMTR Fundamental Analysis
Xometry's revenue trajectory is robust, though specific quarterly figures are not provided; the company's market cap of $3.02 billion and price-to-sales ratio of 4.40 suggest strong revenue growth expectations. The estimated revenue for the next fiscal year is $1.22 billion, implying a significant scale-up from prior periods. The company is not yet profitable, with a trailing net loss reflected in a negative EPS of -$0.02 and a net margin of -9.0%. However, the gross margin of 39.1% is healthy for a manufacturing platform, and the operating margin of -6.6% indicates improving cost efficiency as the company scales. The path to profitability is a key focus, with analysts projecting positive EPS of $1.75 in the coming year, suggesting a sharp turnaround. The balance sheet shows a current ratio of 3.76, indicating strong short-term liquidity, but a debt-to-equity ratio of 1.27 suggests moderate leverage. Return on equity is deeply negative at -22.4%, reflecting the current unprofitability relative to equity base. Free cash flow data is not available, but the price-to-cash-flow ratio of 496.5 implies minimal cash generation relative to market value, highlighting reliance on external financing or future profitability to justify the valuation.
Quarterly Revenue
N/A
N/A
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
N/A
Latest Quarter
Free Cash Flow
N/A
Last 12 Months
Open an Account, get $2 TSLA now!
Valuation Analysis: Is XMTR Overvalued?
Given Xometry's negative net income (EPS -$0.02), the price-to-sales (PS) ratio is the primary valuation metric. The trailing PS ratio is 4.40, while the forward PS (based on estimated revenue of $1.22B and market cap of $3.02B) is approximately 2.47, implying the market expects significant revenue growth to justify the current price. The EV/Sales ratio of 7.00 further confirms a premium valuation. Compared to the industrial machinery industry, Xometry trades at a substantial premium; the industry average PS ratio is typically around 1-2x, making Xometry's 4.40x a 120-340% premium. This premium is justified by the company's high growth rate and AI-enabled platform model, which commands higher multiples. Historically, Xometry's PS ratio has ranged widely; without specific historical data, the current level appears elevated relative to its early post-IPO period, reflecting the market's optimism about its growth trajectory. The negative PEG ratio of -2.64 due to negative earnings further complicates the valuation picture, but the forward PE of 72.1 suggests that if profitability materializes, the stock could be considered reasonably priced for a high-growth tech-enabled industrial.
PE
-48.7x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-89.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Xometry's primary financial risk is its lack of profitability, with a trailing net loss reflected in a negative EPS of -$0.02 and net margin of -9.0%. The debt-to-equity ratio of 1.27 indicates moderate leverage, and the negative ROE of -22.4% highlights inefficiency in generating returns on equity. The company's high cash burn is implied by a price-to-cash-flow ratio of 496.5, suggesting minimal free cash flow generation, which could strain operations if growth decelerates. Revenue concentration in the U.S. segment (majority of revenue) adds geographic risk, and the reliance on continued growth to justify the premium valuation amplifies downside if growth disappoints.
Market & Competitive Risks: Xometry trades at a significant premium to the industrial machinery industry, with a trailing PS ratio of 4.40x versus the industry average of 1-2x, exposing it to valuation compression if growth slows. The stock's beta of 1.27 indicates higher sensitivity to market downturns, and the recent 179.8% surge over the past year suggests potential overextension, making it vulnerable to profit-taking. Competitive risks include the emergence of other digital manufacturing platforms or traditional manufacturers adopting similar AI capabilities, which could erode Xometry's market share. The lack of recent news limits visibility on emerging threats, but the high short ratio of 3.86 indicates significant bearish sentiment.
Worst-Case Scenario: In a worst-case scenario, Xometry fails to achieve projected profitability, revenue growth decelerates sharply, and the market re-rates the stock to a lower multiple. This could drive the price down to the 52-week low of $30.63, representing a 68.9% decline from the current price of $98.54. The analyst low target of $78 implies a 20.8% downside, but if fundamentals deteriorate further, the stock could approach its historical max drawdown of -49.93%, resulting in a loss of approximately 50% from current levels.
FAQ
The key risks include financial risk from lack of profitability (negative EPS of -$0.02 and net margin of -9.0%), which could lead to cash flow issues if growth slows. Valuation risk is high, with a PS ratio of 4.40x versus industry average of 1-2x, making the stock vulnerable to multiple compression. Competitive risk comes from other digital manufacturing platforms and traditional manufacturers adopting AI, which could erode market share. Macro risk is elevated due to a beta of 1.27, meaning the stock amplifies market moves. The most severe risk is a growth deceleration that triggers a re-rating to the 52-week low of $30.63, representing a 68.9% downside from current levels.
The 12-month forecast is balanced across three scenarios. The base case (50% probability) sees the stock trading near the analyst average target of $96.25, with continued growth but margin pressure. The bull case (25% probability) targets $102-$126, driven by faster-than-expected profitability and international expansion. The bear case (25% probability) sees the stock falling to $30.63-$78, if growth decelerates or profitability disappoints. The most likely scenario is the base case, assuming revenue growth of 30-40% and gradual margin improvement. The AI assessment is neutral, reflecting the tension between strong momentum and high valuation.
Xometry is overvalued relative to its industry peers, with a trailing PS ratio of 4.40x compared to the industrial machinery industry average of 1-2x. The forward PS ratio of 2.47x is more reasonable but still reflects a premium for high growth. The forward PE of 72.1x implies that the market expects significant profitability improvements, with analysts projecting EPS of $1.75 next year. Historically, the stock's valuation has been elevated, and the current level suggests the market is pricing in optimistic growth assumptions. Compared to its own history, the stock is near its 52-week high, indicating high investor confidence. Overall, Xometry is overvalued on a trailing basis but may be fairly valued if it achieves its growth and profitability targets.
Xometry is a high-growth stock with strong momentum, but it carries significant risk due to its lack of profitability and premium valuation. The analyst consensus is Buy with an average target of $96.25, implying limited upside from the current price of $98.54. The stock has surged 179.8% over the past year, and while the growth story is compelling, the trailing PS ratio of 4.40x is well above the industry average. For growth-oriented investors with a high risk tolerance, it could be a good buy on pullbacks, but conservative investors may want to wait for evidence of sustainable profitability. The biggest downside risk is a failure to achieve projected EPS of $1.75, which could lead to a sharp re-rating.
Xometry is better suited for long-term investment given its high-growth, early-stage profile, but it carries significant volatility (beta 1.27). The stock has no dividend, so returns depend entirely on price appreciation. Short-term trading could be profitable given the strong momentum, but the risk of a pullback is high after a 179.8% gain in one year. For long-term investors, a minimum holding period of 3-5 years is recommended to allow the company to achieve profitability and realize its growth potential. The current valuation suggests that patience is required, as the stock may experience periods of volatility. The lack of recent earnings visibility adds uncertainty, making it a speculative long-term hold.